Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to compare protein supplements in patients with kidney failure on dialysis. The main questions it aims to answer are: * To determine whether the supplementation of egg white protein pudding in a population of individuals with kidney failure on dialysis is feasible. * To determine whether egg white protein pudding supplementation improves serum albumin similar to other standard nutritional supplements. * To determine the effects of the egg white protein pudding on frailty measures, dietary intakes and analytes in the blood. Participants will receive either the egg white pudding (experimental) or control (Ensure plus) at the end of their dialysis treatments 3-days per week for 12 weeks.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Seven Oaks General Hospital
Winnipeg, Manitoba, Canada
Health Science Centre
Winnipeg, Manitoba, Canada
Start Date
July 25, 2025
Primary Completion Date
June 1, 2026
Completion Date
July 1, 2026
Last Updated
November 17, 2025
54
ESTIMATED participants
Egg white protein pudding
DIETARY_SUPPLEMENT
: Ensure Plus
DIETARY_SUPPLEMENT
Lead Sponsor
Seven Oaks Hospital Chronic Disease Innovation Centre
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions